GLOBAL PROPERTIES OF HIV DYNAMICS MODELS INCLUDING IMPAIRMENT OF B-CELL FUNCTIONS
From MaRDI portal
Publication:5120281
DOI10.1142/S0218339020500011zbMath1445.92269OpenAlexW3004099466MaRDI QIDQ5120281
Aatef Hobiny, Ahmed M. Elaiw, Safiya F. Alshehaiween
Publication date: 9 September 2020
Published in: Journal of Biological Systems (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1142/s0218339020500011
Epidemiology (92D30) Cell biology (92C37) Global stability of solutions to ordinary differential equations (34D23)
Related Items (7)
Global stability analysis of a general nonlinear scabies dynamics model ⋮ Global properties of saturated chikungunya virus dynamics models with cellular infection and delays ⋮ Global dynamics of a general diffusive HBV infection model with capsids and adaptive immune response ⋮ Spatiotemporal dynamics of a delayed viral infection model with two modes of transmission and immune impairment ⋮ Stability of an adaptive immunity delayed HIV infection model with active and silent cell-to-cell spread ⋮ Stability of an adaptive immunity viral infection model with multi-stages of infected cells and two routes of infection ⋮ Global properties of virus dynamics with B-cell impairment
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- HIV-1 infection and low steady state viral loads
- Global properties of basic virus dynamics models
- Dynamical analysis of a delayed reaction-diffusion virus infection model with logistic growth and humoral immune impairment
- Global stability of humoral immunity virus dynamics models with nonlinear infection rate and removal
- Global properties of a class of HIV models
- Global properties for virus dynamics model with Beddington-DeAngelis functional response
- Influence of delayed viral production on viral dynamics in HIV-1 infected patients
- Introduction to functional differential equations
- A mathematical model of cell-to-cell spread of HIV-1 that includes a time delay
- Global properties of delayed-HIV dynamics models with differential drug efficacy in cocirculating target cells
- Stability of delayed pathogen dynamics models with latency and two routes of infection
- HIV/HCV coinfection model: a fractional-order perspective for the effect of the HIV viral load
- Stability of delayed HIV dynamics models with two latent reservoirs and immune impairment
- A model of HIV-1 pathogenesis that includes an intracellular delay
- Hopf bifurcation in a CTL-inclusive HIV-1 infection model with two time delays
- Stabilization in a chemotaxis model for virus infection
- Global stability analysis for delayed virus infection model with general incidence rate and humoral immunity
- Global dynamics of reaction-diffusion oncolytic M1 virotherapy with immune response
- Global properties of a general latent pathogen dynamics model with delayed pathogenic and cellular infections
- Stability analysis of pathogen-immune interaction dynamics
- Global properties of infectious disease models with nonlinear incidence
- Global Stability of a Nonlinear Viral Infection Model with Infinitely Distributed Intracellular Delays and CTL Immune Responses
- GLOBAL STABILITY OF A GENERAL VIRUS DYNAMICS MODEL WITH MULTI-STAGED INFECTED PROGRESSION AND HUMORAL IMMUNITY
- Stability analysis of a virus infection model with humoral immunity response and two time delays
- Modeling HIV-1 Virus Dynamics with Both Virus-to-Cell Infection and Cell-to-Cell Transmission
- Mathematical analysis of an HIV latent infection model including both virus-to-cell infection and cell-to-cell transmission
- Mathematical Analysis of HIV-1 Dynamics in Vivo
- Stability of an adaptive immunity pathogen dynamics model with latency and multiple delays
- Stability of general virus dynamics models with both cellular and viral infections and delays
- Heterogeneous population dynamics of active particles: Progression, mutations, and selection dynamics
- Lyapunov Functionals for Delay Differential Equations Model of Viral Infections
This page was built for publication: GLOBAL PROPERTIES OF HIV DYNAMICS MODELS INCLUDING IMPAIRMENT OF B-CELL FUNCTIONS
